Table 1.
Demographic and clinical characteristics of the COVID-19 cases included in the study
| Italians (N=197 206) |
Non-Italians (N=15 974) |
Non-Italians from low-HDI countries (N=3422) |
Non-Italians from medium-HDI countries (N=8449) |
Non-Italians from high-HDI countries (N=4103) |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| Sex | ||||||||||
| Female | 105 830 | (53.7) | 9103 | (57.0) | 1050 | (30.7) | 5100 | (60.4) | 2953 | (72.0) |
| Male | 91 376 | (46.3) | 6871 | (43.0) | 2372 | (69.3) | 3349 | (39.6) | 1150 | ('28.0) |
| Age group | ||||||||||
| <30 years | 15 794 | (8.0) | 2504 | (15.7) | 993 | (29.0) | 1140 | (13.5) | 371 | (9.0) |
| 30–34 years | 6649 | (3.4) | 1430 | (9.0) | 497 | (14.5) | 664 | (7.9) | 269 | (6.6) |
| 35–39 years | 7040 | (3.6) | 1865 | (11.7) | 496 | (14.5) | 920 | (10.9) | 449 | (10.9) |
| 40–44 years | 9145 | (4.6) | 2339 | (14.6) | 457 | (13.4) | 1247 | (14.8) | 635 | (15.5) |
| 45–49 years | 14 309 | (7.3) | 2246 | (14.1) | 383 | (11.2) | 1189 | (14.1) | 674 | (16.4) |
| 50–54 years | 17 055 | (8.6) | 1989 | (12.5) | 229 | (6.7) | 1141 | (13.5) | 619 | (15.1) |
| 55–59 years | 17 677 | (9.0) | 1434 | (9.0) | 157 | (4.6) | 887 | (10.5) | 390 | (9.5) |
| 60–64 years | 14 499 | (7.4) | 894 | (5.6) | 101 | (3.0) | 539 | (6.4) | 254 | (6.2) |
| 65.69 years | 12 501 | (6.3) | 506 | (3.2) | 53 | (1.5) | 327 | (3.9) | 126 | (3.1) |
| 70–74 years | 14 307 | (7.3) | 261 | (1.6) | 23 | (0.7) | 171 | (2.0) | 67 | (1.6) |
| ≥75 years | 68 225 | (34.6) | 506 | (3.2) | 33 | (1.0) | 224 | (2.7) | 249 | (6.1) |
| Median age (IQR) | 63 years | (48–80) | 44 years | (35–53) | 37 years | (28–46) | 45 years | (36–55) | 47 years | (39–55) |
| Geographical macro-area | ||||||||||
| North-West | 106 276 | (53.9) | 9662 | (60.5) | 1714 | (50.1) | 5668 | (67.1) | 2280 | (55.6) |
| North-East | 54 224 | (27.5) | 4737 | (29.7) | 1303 | (38.1) | 2086 | (24.7) | 1348 | (32.9) |
| Centre | 21 496 | (10.9) | 1198 | (7.5) | 328 | (9.6) | 554 | (6.6) | 316 | (7.7) |
| South and Islands | 15 210 | (7.7) | 377 | (2.4) | 77 | (2.3) | 141 | (1.7) | 159 | (3.9) |
| Level of urbanization | ||||||||||
| Urban | 64 802 | (33.1) | 8172 | (52.0) | 1843 | (55.1) | 4764 | (57.1) | 1565 | (38.8) |
| Semi-urban | 94 623 | (48.3) | 5950 | (37.8) | 1212 | (36.2) | 2863 | (34.3) | 1875 | (46.5) |
| Rural | 36 453 | (18.6) | 1606 | (10.2) | 290 | (8.7) | 721 | (8.6) | 595 | (14.7) |
| Pre-existing comorbiditiesa | ||||||||||
| No | 118 236 | (60.2) | 13 141 | (83.5) | 2893 | (87.0) | 6878 | (82.5) | 3370 | (82.8) |
| Yes | 78 283 | (39.8) | 2597 | (16.5) | 433 | (13.0) | 1464 | (17.5) | 700 | (17.2) |
| Period of diagnosis | ||||||||||
| 20 February–19 March | 46 315 | (23.5) | 2033 | (12.7) | 297 | (8.7) | 1133 | (13.4) | 603 | (14.7) |
| 20 March–19 April | 103 614 | (52.5) | 6902 | (43.2) | 1092 | (31.9) | 3910 | (46.3) | 1900 | (46.3) |
| 20 April–19 May | 34 597 | (17.5) | 3993 | (25.0) | 788 | (23.0) | 2115 | (25.0) | 1090 | (26.6) |
| 20 May–19 June | 9190 | (4.7) | 1324 | (8.3) | 315 | (9.2) | 730 | (8.6) | 279 | (6.8) |
| 20 June–19 July | 3490 | (1.8) | 1722 | (10.8) | 930 | (27.2) | 561 | (6.6) | 231 | (5.6) |
IQR, interquartile range.
The number of cases might not add to the total because of missing information.
a
At least one of oncologic, cardiovascular, respiratory and diabetes/metabolic diseases.